×
Dynatronics Net Income 2010-2024 | DYNT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Dynatronics net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Historical Chart (TTM)
Quarterly
Annual
Quarterly - YOY Change
Annual % Change
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$199.9B
Intuitive Surgical (ISRG)
$186.6B
Edwards Lifesciences (EW)
$42.8B
Alcon (ALC)
$41.2B
IQVIA Holdings (IQV)
$35.4B
IDEXX Laboratories (IDXX)
$33.5B
DexCom (DXCM)
$30.7B
Waters (WAT)
$21.9B
STERIS (STE)
$20B
SONOVA HOLDING (SONVY)
$19.3B
Hologic (HOLX)
$16.3B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$11.4B
Globus Medical (GMED)
$11.1B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$9B
Teleflex (TFX)
$8.3B
Glaukos (GKOS)
$8.3B
Integer Holdings (ITGR)
$4.4B
PROCEPT BioRobotics (PRCT)
$4.3B
Veracyte (VCYT)
$3.1B
Inari Medical (NARI)
$3B
LivaNova (LIVN)
$2.5B
Tandem Diabetes Care (TNDM)
$2.4B
Nihon Kohden (NHNKY)
$2.3B
TransMedics (TMDX)
$2.2B
Elekta AB (EKTAY)
$2.1B
Integra LifeSciences Holdings (IART)
$1.8B
RxSight (RXST)
$1.4B
Alphatec Holdings (ATEC)
$1.3B